van Rheede, Joram J. http://orcid.org/0000-0001-8164-8594
Alagapan, Sankaraleengam http://orcid.org/0000-0002-2056-5450
Denison, Timothy J.
Riva-Posse, Patricio http://orcid.org/0000-0002-5887-0557
Rozell, Christopher J. http://orcid.org/0000-0001-5173-1661
Mayberg, Helen S. http://orcid.org/0000-0002-1672-2716
Waters, Allison C.
Sharott, Andrew http://orcid.org/0000-0002-1594-3349
Funding for this research was provided by:
RCUK | Medical Research Council (MC_UU_00003/6, MC_UU_00003/3, MC_UU_00003/6)
Hope for Depression Research Foundation (NIH UH3NS103550, NIH UH3NS103550, NIH UH3NS103550)
U.S. Department of Health & Human Services | NIH | National Center for Advancing Translational Sciences (KL2TR002381)
Article History
Received: 3 November 2023
Revised: 17 January 2024
Accepted: 1 February 2024
First Online: 20 February 2024
Competing interests
: JR has received honoraria from Medtronic. TD is a founder and director of Amber who own Bioinduction Ltd, has received honoraria from Medtronic, and is an advisor for Cortec Neuro and Synchron. PR-P receives consulting fees from Abbott Labs, LivaNova, and Janssen Pharmaceuticals. HM receives consulting and Intellectual Property licensing fees from Abbott Labs. SA, CR, AW, and AS have nothing to declare.